Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

One-Minute movement breaks: a new way to fight obesity?

NCT ID NCT06924346

Symptom relief Sponsor: University of British Columbia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study tests whether brief, one-minute exercise breaks—called 'exercise snacks'—can improve fitness and health in adults with obesity. Eighty inactive participants aged 35-64 will use a phone app to do personalized movement breaks throughout the day for 12 weeks. The goal is to see if this approach is practical and can boost cardiorespiratory fitness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exercise snacks (short movement breaks delivered via mobile app)
What this could lead to
If it works, this could offer a simple, flexible way for people with obesity to improve their fitness and heart health without long gym sessions.
What could go wrong
This is a small, early feasibility study (80 participants) testing whether people will stick with the program. It may not show clear health benefits or work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

72 people

The number who actually took part.

Started

Jul 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 64 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 35-64 years. * Habitually engaging in \< 150 min moderate-to-vigorous physical activity per week. * Body mass index 30-45 kg/m2 or 27.5-45 for participants who self-identify as being of Asian or Southeast Asian origin. * Waist circumference: \>88cm for females and \>102cm for males, or \>80 cm for females and \>90 cm for male participants who self-identify as being of Asian or Southeast Asian. * Not currently diagnosed with a cardiometabolic disease (e.g., coronary artery disease, stroke, diabetes, non-alcoholic fatty liver disease). * Taking ≤2 commonly prescribed medications for the prevention of cardiometabolic diseases (e.g., statins, antihypertensives). * Not a current smoker * Cleared to engage in physical activity using the Get Active Questionnaire and, if applicable, consultation with a health care provider or Qualified Exercise Professional. * Access to a computer, tablet or smartphone for intervention delivery and tracking. * Ability to read and write in English. Exclusion Criteria: * Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise. * Lack of internet access. * Angina upon exertion assessed by the Rose Angina Questionnaire. * Prescribed beta-blockers that can compromise the validity of heart rate measurements. during the exercise test. * Have a scheduled surgical procedure within the next 3-4 months that would prevent exercise participation. * Currently participating in another clinical trial that interferes with the study procedures. * Currently pregnant or planning on becoming pregnant during the intervention (i.e., within the next 4 months). * Uncontrolled high blood pressure (\>160/90 mmHg)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity

Contacts and locations

Locations

  • McMaster University

    Hamilton, Ontario, Canada

  • University of British Columbia Okanagan

    Kelowna, British Columbia, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.